1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office COP300
Email jamie-miller@ou.edu
Publications & Presentations
- 111. Oldham M M, Burton M E, Johnson P N, Miller J L. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014; 71 : 2108-9
112. Chandler C, Miller J L, Cunnyngham C, Johnson P N. Propylene-glycol induced lactic acidosis in a child receiving a pentobarbital continuous infusion. Journal of Pediatric Intensive Care. 2014; 3 : 73-77
113. Lammers E M, Johnson P N, Ernst K D, Hagemann T M, Lawrence S M, Williams P K, Anderson M, Miller J L. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. The Annals of pharmacotherapy. 2014; 48 : 335-42
114. Johnson P N, Miller J L, Hagemann T M, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. The Annals of pharmacotherapy. 2014; 48 : 187-95
115. Miller J L, Schaefer J, Tam M, Johnson P N. Ethacrynic acid continuous infusions in critically-ill pediatric patients. Journal of Pediatric Pharmacology and Therapeutics. 2014; 18 : 167
Grants
- 1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.
2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
Awards and Honors
- 11. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
12. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.
13. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.
14. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
15. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.